Amalgamated Bank’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.82M | Sell |
22,281
-678
| -3% | -$49K | 0.01% | 882 |
|
|
2026
Q1 | $1.56M | Sell |
22,959
-163
| -0.7% | -$11.5K | 0.01% | 904 |
|
|
2025
Q4 | $1.76M | Buy |
23,122
+20,604
| +818% | +$1.5M | 0.01% | 871 |
|
|
2025
Q3 | $155K | Sell |
2,518
-119
| -5% | -$6.2K | ﹤0.01% | 1629 |
|
|
2025
Q2 | $129K | Hold |
2,637
| – | – | ﹤0.01% | 1657 |
|
|
2025
Q1 | $134K | Buy |
2,637
+108
| +4% | +$5.39K | ﹤0.01% | 1621 |
|
|
2024
Q4 | $114K | Hold |
2,529
| – | – | ﹤0.01% | 1676 |
|
|
2024
Q3 | $94K | Hold |
2,529
| – | – | ﹤0.01% | 1717 |
|
|
2024
Q2 | $77K | Buy |
2,529
+125
| +5% | +$4.05K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $70K | Sell |
2,404
-7,088
| -75% | -$199K | ﹤0.01% | 1788 |
|
|
2023
Q4 | $262K | Sell |
9,492
-715
| -7% | -$16.4K | ﹤0.01% | 1712 |
|
|
2023
Q3 | $229K | Buy |
10,207
+190
| +2% | +$7.07K | ﹤0.01% | 1739 |
|
|
2023
Q2 | $407K | Buy |
10,017
+677
| +7% | +$33.1K | ﹤0.01% | 1530 |
|
|
2023
Q1 | $452K | Sell |
9,340
-1,590
| -15% | -$72.7K | ﹤0.01% | 1466 |
|
|
2022
Q4 | $417K | Buy |
10,930
+184
| +2% | +$7.65K | ﹤0.01% | 1548 |
|
|
2022
Q3 | $539K | Buy |
10,746
+155
| +1% | +$7.59K | 0.01% | 1394 |
|
|
2022
Q2 | $424K | Sell |
10,591
-779
| -7% | -$27.3K | ﹤0.01% | 1537 |
|
|
2022
Q1 | $424K | Sell |
11,370
-854
| -7% | -$32.9K | ﹤0.01% | 1625 |
|
|
2021
Q4 | $487K | Sell |
12,224
-131
| -1% | -$5.01K | ﹤0.01% | 1593 |
|
|
2021
Q3 | $460K | Sell |
12,355
-761
| -6% | -$31.3K | ﹤0.01% | 1625 |
|
|
2021
Q2 | $554K | Buy |
13,116
+4,317
| +49% | +$185K | ﹤0.01% | 1591 |
|
|
2021
Q1 | $417K | Sell |
8,799
-860
| -9% | -$51.1K | 0.02% | 1077 |
|
|
2020
Q4 | $589K | Buy |
9,659
+50
| +0.5% | +$2.95K | 0.02% | 862 |
|
|
2020
Q3 | $449K | Sell |
9,609
-278
| -3% | -$13.7K | 0.02% | 902 |
|
|
2020
Q2 | $502K | Sell |
9,887
-913
| -8% | -$44.9K | 0.02% | 835 |
|
|
2020
Q1 | $482K | Sell |
10,800
-338
| -3% | -$17K | 0.01% | 931 |
|
|
2019
Q4 | $535K | Buy |
11,138
+990
| +10% | +$42.1K | 0.01% | 1079 |
|
|
2019
Q3 | $343K | Sell |
10,148
-127
| -1% | -$5.53K | 0.01% | 1236 |
|
|
2019
Q2 | $462K | Buy |
10,275
+2,753
| +37% | +$109K | 0.01% | 1110 |
|
|
2019
Q1 | $283K | Buy |
7,522
+890
| +13% | +$29.9K | 0.01% | 1303 |
|
|
2018
Q4 | $228K | Buy |
+6,632
| New | +$238K | 0.01% | 1334 |
|
|
2018
Q3 | – | Sell |
-6,896
| Closed | -$233K | – | 1583 |
|
|
2018
Q2 | $233K | Buy |
+6,896
| New | +$215K | 0.01% | 1471 |
|
Other funds holding PTCT
RI
JT
Amalgamated Bank's PTCT Position: Q2 2026 in Review
Amalgamated Bank reduced its PTC Therapeutics (PTCT) stake by 3% in Q2 2026, selling an estimated $49K and leaving 22,281 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #882.
Amalgamated Bank first reported a position in PTCT in Q2 2018 and has held it in 32 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Amalgamated Bank held 22,281 shares of PTC Therapeutics worth $1.82M as of Q2 2026.
- Amalgamated Bank sold 678 PTC Therapeutics shares in Q2 2026, an estimated $49K.
- PTC Therapeutics made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #882 holding.
- Amalgamated Bank first reported a position in PTC Therapeutics in Q2 2018 and has held it in 32 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.